Skip to main content
Login
Contact
Subscribe
Search form
Search
The Sweetwater Reporter
Home
Forms
News
Sports
Classifieds
Obituaries
Entertainment
Local Guide
Special Sections
Talking About...
Photos
Videos
Games
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Catalyst Bio
(NQ:
CBIO
)
5.390
USD
+0.020 (+0.37%)
Official Closing Price
/ Updated:
5:48 PM EDT, Aug 7, 2020
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
152,600
Open
5.390
Bid (Size)
4.940 (1)
Ask (Size)
5.950 (1)
Prev. Close
5.370
Today's Range
5.300 - 5.505
52wk Range
3.430 - 8.940
Shares Outstanding
11,935,169
Dividend Yield
N/A
Performance
YTD
-17.08%
-17.08%
1 Month
-8.02%
-8.02%
3 Month
-20.97%
-20.97%
6 Month
-36.59%
-36.59%
1 Year
-29.73%
-29.73%
Top News
More News
Catalyst Biosciences Reports Second Quarter 2020 Operating & Financial Results and Provides a Corporate Update
August 06, 2020
from
GlobeNewswire News Releases
Catalyst Biosciences Presents Data at the International Society for Thrombosis and Haemostasis (ISTH) Virtual Congress
July 13, 2020
from
GlobeNewswire News Releases
More News
Read More
Catalyst Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 01, 2020
from
GlobeNewswire News Releases
Catalyst Biosciences Added to Russell 2000 Index
June 29, 2020
from
GlobeNewswire News Releases
Catalyst Biosciences Announces Presentations at the International Society on Thrombosis and Haemostasis
June 29, 2020
from
GlobeNewswire News Releases
Catalyst Biosciences Announces Closing of Public Offering of Common Stock
June 22, 2020
from
GlobeNewswire News Releases
Catalyst Biosciences Appoints Charles Democko, Senior Vice President, Regulatory Affairs
June 22, 2020
from
GlobeNewswire News Releases
Catalyst Biosciences Presents Preclinical FIX Gene Therapy Data in an Oral Presentation at the World Federation of Hemophilia Virtual Summit 2020
June 19, 2020
from
GlobeNewswire News Releases
Catalyst Biosciences Announces Pricing of Public Offering of Common Stock
June 18, 2020
from
GlobeNewswire News Releases
Catalyst Biosciences Announces Proposed Public Offering of Common Stock
June 17, 2020
from
GlobeNewswire News Releases
Valneva Announces Successful Outcome of its AGM and the Appointment of two new Supervisory Board Members
June 17, 2020
from
GlobeNewswire News Releases
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
